ELECTRICAL STIMULATION DEVICES FOR CANCER TREATMENT

    公开(公告)号:US20200330756A1

    公开(公告)日:2020-10-22

    申请号:US16850712

    申请日:2020-04-16

    Abstract: Embodiments herein relate to a medical device for treating a cancerous tumor, the medical device having a first lead including a first wire and second wire; a second lead can include a third wire and fourth wire; and a first electrode in electrical communication with the first wire, a second electrode in electrical communication with the second wire, a third electrode in electrical communication with the third wire, and a fourth electrode in electrical communication with the fourth wire. The first and third electrodes form a supply electrode pair configured to deliver one or more electric fields to the cancerous tumor. The second and fourth electrodes form a sensing electrode pair configured to measure an impedance of the cancerous tumor independent of an impedance of the first electrode, the first wire, the third electrode, the third wire, and components in electrical communication therewith. Other embodiments are also included herein.

    INTERACTIVE WEARABLE AND E-TATTOO COMBINATIONS

    公开(公告)号:US20190151640A1

    公开(公告)日:2019-05-23

    申请号:US16196934

    申请日:2018-11-20

    Abstract: A system for monitoring one or more respiratory conditions is disclosed. The system comprises a medical device and an e-tattoo configured to attach to the subject's skin. The medical device is configured to monitor at least one respiratory parameter of a subject and transmit a signal in response to monitoring a trigger event in the at least one respiratory parameter. The e-tattoo is configured to: receive the signal from the medical device; sense at least one environmental parameter in response to receiving the signal; and transmit the at least one environmental parameter.

    Electrical stimulation devices for cancer treatment

    公开(公告)号:US11691006B2

    公开(公告)日:2023-07-04

    申请号:US16850712

    申请日:2020-04-16

    CPC classification number: A61N1/36002 A61B5/0538 A61N1/05

    Abstract: Embodiments herein relate to a medical device for treating a cancerous tumor, the medical device having a first lead including a first wire and second wire; a second lead can include a third wire and fourth wire; and a first electrode in electrical communication with the first wire, a second electrode in electrical communication with the second wire, a third electrode in electrical communication with the third wire, and a fourth electrode in electrical communication with the fourth wire. The first and third electrodes form a supply electrode pair configured to deliver one or more electric fields to the cancerous tumor. The second and fourth electrodes form a sensing electrode pair configured to measure an impedance of the cancerous tumor independent of an impedance of the first electrode, the first wire, the third electrode, the third wire, and components in electrical communication therewith. Other embodiments are also included herein.

    MEDICAL SYSTEM FOR TREATING A LEFT ATRIAL APPENDAGE

    公开(公告)号:US20220218355A1

    公开(公告)日:2022-07-14

    申请号:US17575154

    申请日:2022-01-13

    Abstract: A medical system may include a left atrial appendage closure device including an expandable framework and a proximal hub disposed along a central longitudinal axis of the expandable framework, the expandable framework being configured to shift between a collapsed delivery configuration and an expanded deployed configuration; wherein the left atrial appendage closure device includes a sensor at least partially disposed within an interior of the expandable framework and axially movable relative to the proximal hub; wherein the proximal hub includes a first threaded connection structure; and a delivery catheter including a core wire extending axially within a lumen of the delivery catheter, the core wire having a second threaded connection structure at a distal end thereof configured to releasably engage the first threaded connection structure in an unreleased configuration and the second threaded connection structure is disengaged from the first threaded connection structure in a released configuration.

    MEDICAL SYSTEM FOR TREATING A LEFT ATRIAL APPENDAGE

    公开(公告)号:US20210298763A1

    公开(公告)日:2021-09-30

    申请号:US17209938

    申请日:2021-03-23

    Abstract: A medical system may include a left atrial appendage closure device including an expandable framework and a proximal hub centered on a central longitudinal axis of the framework. An insert may be disposed within the proximal hub and include a collar configured to engage the proximal hub, a recess extending into the insert from a proximal end, and a post member disposed within the recess. The post member may be radially spaced apart from the collar and may extend proximally from a distal end of the recess to a proximal surface. The insert may include a first connection structure disposed distal of the proximal surface. The medical system may include a delivery catheter having a second connection structure configured to engage the first connection structure in a delivery configuration. The distal end of the delivery catheter includes a hollow portion configured to receive the post member in the delivery configuration.

    ELECTRICAL STIMULATION WITH THERMAL TREATMENT OR THERMAL MONITORING

    公开(公告)号:US20200338346A1

    公开(公告)日:2020-10-29

    申请号:US16855448

    申请日:2020-04-22

    Abstract: Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having an electric field generating circuit configured to generate one or more electric fields and a control circuit in communication with the electric field generating circuit. The control circuit configured to control delivery of the one or more electric fields from the electric field generating circuit. The system can include two or more electrodes to deliver the electric fields to a site of a cancerous tumor within a patient and a temperature sensor to measure the temperature of tissue at the site of the cancerous tumor. The control circuit can cause the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz. Other embodiments are also included herein.

Patent Agency Ranking